|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
21 November 2016 |
|
Main ID: |
NCT02963129 |
|
Date of registration:
|
09/08/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
|
|
Scientific title:
|
Treatment of Nasal Staphylococcus Aureus Colonization in Patients With Hereditary Hemorrhagic Telangiectasia With Recurrent Epistaxis. |
|
Date of first enrolment:
|
June 2017 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02963129 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Argentina
| | | | | | | |
|
Contacts
|
|
Name:
|
Marcelo MS Serra, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Staff of the Department of Clinical Medicine |
|
|
Name:
|
Marcelo MS Serra, MD |
|
Address:
|
|
|
Telephone:
|
49590200 |
|
Email:
|
marcelo.serra@hospitalitalino.org.ar |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients over 18 years with possible or confirmed HHT as diagnostic criteria Curaçao.
- Patients with nasal S. aureus colonization culture positive
Exclusion Criteria:
- Refusal to participate in the study or the informed consent process.
- Hypersensitivity or contraindication for topical mupirocin.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hereditary Hemorrhagic Telangiectasia
|
|
Epistaxis
|
|
Intervention(s)
|
|
Drug: Mupirocin
|
|
Other: Placebo
|
|
Primary Outcome(s)
|
|
Nosebleed by sadick scale
[Time Frame: 60 days]
|
|
Secondary Outcome(s)
|
|
Prevalence of nasal colonization with Staphylococcus in patients with HHT by nasal cultive
[Time Frame: 60 days]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|